title: Helicobacter heilmannii gastroduodenal disease and clinical aspects in children with dyspeptic symptoms.
abstract: OBJECTIVE
  To evaluate the occurrence and clinical characteristics of Helicobacter heilmannii infection among children presenting with dyspeptic symptoms.
  
  
  METHODS
  Prospective cohort study of 580 patients.
  
  
  RESULTS
  Of all examined dyspeptic children, 26.4% were infected with spiral-shaped organisms, and 0.9% of patients were found to be infected with spiral H. heilmannii-like organisms.
  
  
  CONCLUSIONS
  In children with dyspeptic symptoms, the possible presence of gastroduodenal disease due to H. heilmannii should be considered. Further studies are needed to clarify H. heilmannii-related gastroduodenal pathology in the paediatric population.
authors.affiliation: Department of Paediatrics, Charles University Hospital, Pilsen, Czech Republic. sykorajo@fnplzen.cz
authors.forename: J
authors.initials: J
authors.lastname: Sýkora
authors.forename: V
authors.initials: V
authors.lastname: Hejda
authors.forename: J
authors.initials: J
authors.lastname: Varvarovská
authors.forename: F
authors.initials: F
authors.lastname: Stozický
authors.forename: K
authors.initials: K
authors.lastname: Siala
authors.forename: J
authors.initials: J
authors.lastname: Schwarz
mesh_terms: D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D015331:Cohort Studies; D018153:Czech Republic / Q000453:epidemiology; D005260:Female; D005767:Gastrointestinal Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D016481:Helicobacter Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D018247:Helicobacter heilmannii / Q000187:drug effects / Q000302:isolation & purification*; D016480:Helicobacter pylori / Q000187:drug effects / Q000302:isolation & purification; D006801:Humans; D008297:Male; D015995:Prevalence; D011446:Prospective Studies; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents